Literature DB >> 21364282

The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice.

Mirco Castoldi1, Maja Vujic Spasic, Sandro Altamura, Joacim Elmén, Morten Lindow, Judit Kiss, Jens Stolte, Richard Sparla, Lorenza A D'Alessandro, Ursula Klingmüller, Robert E Fleming, Thomas Longerich, Hermann J Gröne, Vladimir Benes, Sakari Kauppinen, Matthias W Hentze, Martina U Muckenthaler.   

Abstract

Systemic iron homeostasis is mainly controlled by the liver through synthesis of the peptide hormone hepcidin (encoded by Hamp), the key regulator of duodenal iron absorption and macrophage iron release. Here we show that the liver-specific microRNA miR-122 is important for regulating Hamp mRNA expression and tissue iron levels. Efficient and specific depletion of miR-122 by injection of a locked-nucleic-acid-modified (LNA-modified) anti-miR into WT mice caused systemic iron deficiency, characterized by reduced plasma and liver iron levels, mildly impaired hematopoiesis, and increased extramedullary erythropoiesis in the spleen. Moreover, miR-122 inhibition increased the amount of mRNA transcribed by genes that control systemic iron levels, such as hemochromatosis (Hfe), hemojuvelin (Hjv), bone morphogenetic protein receptor type 1A (Bmpr1a), and Hamp. Importantly, miR-122 directly targeted the 3′ untranslated region of 2 mRNAs that encode activators of hepcidin expression, Hfe and Hjv. These data help to explain the increased Hamp mRNA levels and subsequent iron deficiency in mice with reduced miR-122 levels and establish a direct mechanistic link between miR-122 and the regulation of systemic iron metabolism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21364282      PMCID: PMC3069782          DOI: 10.1172/JCI44883

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  74 in total

Review 1.  miR-122, a paradigm for the role of microRNAs in the liver.

Authors:  Muriel Girard; Emmanuel Jacquemin; Arnold Munnich; Stanislas Lyonnet; Alexandra Henrion-Caude
Journal:  J Hepatol       Date:  2008-02-12       Impact factor: 25.083

2.  A GATA-1-regulated microRNA locus essential for erythropoiesis.

Authors:  Louis C Dore; Julio D Amigo; Camila O Dos Santos; Zhe Zhang; Xiaowu Gai; John W Tobias; Duonan Yu; Alyssa M Klein; Christine Dorman; Weisheng Wu; Ross C Hardison; Barry H Paw; Mitchell J Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-26       Impact factor: 11.205

3.  LNA-mediated microRNA silencing in non-human primates.

Authors:  Joacim Elmén; Morten Lindow; Sylvia Schütz; Matthew Lawrence; Andreas Petri; Susanna Obad; Marie Lindholm; Maj Hedtjärn; Henrik Frydenlund Hansen; Urs Berger; Steven Gullans; Phil Kearney; Peter Sarnow; Ellen Marie Straarup; Sakari Kauppinen
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

4.  Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver.

Authors:  Léon Kautz; Delphine Meynard; Annabelle Monnier; Valérie Darnaud; Régis Bouvet; Rui-Hong Wang; Chiuxia Deng; Sophie Vaulont; Jean Mosser; Hélène Coppin; Marie-Paule Roth
Journal:  Blood       Date:  2008-06-06       Impact factor: 22.113

5.  Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA).

Authors:  Karin E Finberg; Matthew M Heeney; Dean R Campagna; Yeşim Aydinok; Howard A Pearson; Kip R Hartman; Mary M Mayo; Stewart M Samuel; John J Strouse; Kyriacos Markianos; Nancy C Andrews; Mark D Fleming
Journal:  Nat Genet       Date:  2008-04-13       Impact factor: 38.330

6.  miR-451 regulates zebrafish erythroid maturation in vivo via its target gata2.

Authors:  Luke Pase; Judith E Layton; Wigard P Kloosterman; Duncan Carradice; Peter M Waterhouse; Graham J Lieschke
Journal:  Blood       Date:  2008-10-10       Impact factor: 22.113

7.  Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy.

Authors:  Magdalena Sarasin-Filipowicz; Jacek Krol; Ilona Markiewicz; Markus H Heim; Witold Filipowicz
Journal:  Nat Med       Date:  2009-01-04       Impact factor: 53.440

8.  Regulation of hepatitis C virus by microRNA-122.

Authors:  Catherine L Jopling
Journal:  Biochem Soc Trans       Date:  2008-12       Impact factor: 5.407

9.  The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2.

Authors:  Jeffrey M Friedman; Gangning Liang; Chun-Chi Liu; Erika M Wolff; Yvonne C Tsai; Wei Ye; Xianghong Zhou; Peter A Jones
Journal:  Cancer Res       Date:  2009-03-03       Impact factor: 12.701

10.  The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.

Authors:  Laura Silvestri; Alessia Pagani; Antonella Nai; Ivana De Domenico; Jerry Kaplan; Clara Camaschella
Journal:  Cell Metab       Date:  2008-10-30       Impact factor: 27.287

View more
  108 in total

1.  Advanced molecular biologic techniques in toxicologic disease.

Authors:  Jeanine Ward; Gyongyi Szabo; David McManus; Edward Boyer
Journal:  J Med Toxicol       Date:  2011-12

Review 2.  Unraveling mechanisms regulating systemic iron homeostasis.

Authors:  Karin E Finberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

Review 3.  Murine mutants in the study of systemic iron metabolism and its disorders: an update on recent advances.

Authors:  Thomas B Bartnikas; Mark D Fleming; Paul J Schmidt
Journal:  Biochim Biophys Acta       Date:  2012-01-28

4.  Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus.

Authors:  Takasuke Fukuhara; Hiroto Kambara; Mai Shiokawa; Chikako Ono; Hiroshi Katoh; Eiji Morita; Daisuke Okuzaki; Yoshihiko Maehara; Kazuhiko Koike; Yoshiharu Matsuura
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 5.  MicroRNA: a connecting road between apoptosis and cholesterol metabolism.

Authors:  Yogita K Adlakha; Neeru Saini
Journal:  Tumour Biol       Date:  2016-04-22

6.  Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure.

Authors:  Shu-Hao Hsu; Bo Wang; Huban Kutay; Hemant Bid; Julia Shreve; Xiaoli Zhang; Stefan Costinean; Anna Bratasz; Peter Houghton; Kalpana Ghoshal
Journal:  Am J Pathol       Date:  2013-10-08       Impact factor: 4.307

Review 7.  MicroRNAs: a connection between cholesterol metabolism and neurodegeneration.

Authors:  Leigh Goedeke; Carlos Fernández-Hernando
Journal:  Neurobiol Dis       Date:  2014-06-05       Impact factor: 5.996

8.  Opposing roles of C/EBPα and eEF1A1 in Sp1-regulated miR-122 transcription.

Authors:  Chunxian Zeng; Ye Sang; Feng-Yi Wang; Shi-Mei Zhuang
Journal:  RNA Biol       Date:  2019-10-07       Impact factor: 4.652

9.  Hepatitis C virus RNA functionally sequesters miR-122.

Authors:  Joseph M Luna; Troels K H Scheel; Tal Danino; Katharina S Shaw; Aldo Mele; John J Fak; Eiko Nishiuchi; Constantin N Takacs; Maria Teresa Catanese; Ype P de Jong; Ira M Jacobson; Charles M Rice; Robert B Darnell
Journal:  Cell       Date:  2015-03-12       Impact factor: 41.582

10.  Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion.

Authors:  Changfei Li; Yanzhong Wang; Saifeng Wang; Bo Wu; Junli Hao; Hongxia Fan; Ying Ju; Yuping Ding; Lizhao Chen; Xiaoyu Chu; Wenjun Liu; Xin Ye; Songdong Meng
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.